Free tool
Stocks listed on B3 São Paulo
We cover 52 companies listed on B3 São Paulo. The median market value in the group is $42.62B. Across the group, the median move over the past trading day is 0.00%. 56% of the 52 with a 200-day average trade above it. Price change over the past year runs from −78.9% to +47.3% across the middle 80 percent of the group, with a median of +2.0%.
Other lists in this group
Table
52 of 2,037 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| ABTT34.SA | Abbott Laboratories | 49.40 BRL | +7.95% | −11.54% | −16.35% |
| GILD34.SA | Gilead Sciences, Inc. | 63.72 BRL | −81.50% | −81.40% | −79.11% |
| PFIZ34.SA | Pfizer Inc. | 36.48 BRL | +12.73% | +10.34% | +11.58% |
| DHER34.SA | Danaher Corporation | 39.85 BRL | +9.12% | −10.44% | +0.89% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | 88.56 BRL | +14.82% | −85.60% | −83.18% |
| BMYB34.SA | Bristol-Myers Squibb Company | 349.41 BRL | +12.49% | +17.24% | +40.74% |
| I1SR34.SA | Intuitive Surgical, Inc. | 95.28 BRL | +2.14% | −37.90% | −25.36% |
| S1YK34.SA | Stryker Corporation | 84.97 BRL | −3.57% | −13.76% | −19.51% |
| MDTC34.SA | Medtronic plc | 59.52 BRL | +13.44% | −77.24% | −75.74% |
| G1SK34.SA | GSK plc | 53.80 BRL | +4.47% | +1.87% | +27.31% |
| M1CK34.SA | McKesson Corporation | 72.17 BRL | +2.08% | −93.69% | −92.49% |
| H1CA34.SA | HCA Healthcare, Inc. | 112.22 BRL | +4.87% | −11.77% | +2.99% |
| E1LV34.SA | Elevance Health, Inc. | 410.80 BRL | +3.62% | +6.85% | +21.66% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | 70.98 BRL | +20.22% | +2.34% | +33.80% |
| C1IC34.SA | The Cigna Group | 59.58 BRL | −3.85% | −84.24% | −85.33% |
| B1SX34.SA | Boston Scientific Corporation | 62.21 BRL | +4.52% | −87.91% | −89.24% |
| M1RN34.SA | Moderna, Inc. | 38.45 BRL | +173.08% | +353.42% | +462.13% |
| A1RG34.SA | argenx SE | 209.16 BRL | +14.71% | +11.37% | +36.97% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | 92.25 BRL | +2.81% | +12.61% | +18.03% |
| C1AH34.SA | Cardinal Health, Inc. | 1,234.64 BRL | +2.68% | +6.79% | +52.41% |
| C1CO34.SA | Cencora, Inc. | 707.04 BRL | 0.00% | −22.88% | −12.17% |
| B1DX34.SA | Becton, Dickinson and Company | 195.72 BRL | +39.80% | −113.58% | −113.87% |
| E1WL34.SA | Edwards Lifesciences Corporation | 105.71 BRL | 0.00% | −8.81% | −4.72% |
| H1UM34.SA | Humana Inc. | 44.52 BRL | +0.95% | +39.09% | +24.36% |
| I1DX34.SA | IDEXX Laboratories, Inc. | 572.47 BRL | −0.27% | −24.21% | −17.31% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | 97.74 BRL | +24.04% | +17.29% | +94.70% |
| V2EE34.SA | Veeva Systems Inc. | 43.28 BRL | +37.40% | +4.74% | −18.65% |
| A1GI34.SA | Agilent Technologies, Inc. | 72.26 BRL | +7.99% | −81.18% | −77.37% |
| WATC34.SA | Waters Corporation | 476.58 BRL | 0.00% | −9.22% | +24.76% |
| I1LM34.SA | Illumina, Inc. | 232.57 BRL | +19.43% | +55.21% | +113.13% |
| D1EX34.SA | DexCom, Inc. | 9.21 BRL | +28.45% | +22.96% | +9.64% |
| C1NC34.SA | Centene Corporation | 340.30 BRL | −2.49% | +53.30% | +116.61% |
| BIIB34.SA | Biogen Inc. | 188.29 BRL | +9.47% | +16.95% | +47.86% |
| Z1TS34.SA | Zoetis Inc. | 24.94 BRL | +0.56% | −40.91% | −52.31% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | 62.25 BRL | −15.31% | −44.14% | −49.35% |
| B1NT34.SA | BioNTech SE | 36.04 BRL | +21.72% | +9.71% | +2.68% |
| R1MD34.SA | ResMed Inc. | 243.85 BRL | 0.00% | −26.80% | −38.24% |
| I1NC34.SA | Incyte Corporation | 328.02 BRL | +11.19% | +18.38% | +41.91% |
| S1TE34.SA | STERIS plc | 52.14 BRL | 0.00% | −19.10% | −18.78% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | 121.92 BRL | +6.75% | +6.21% | −5.04% |
| N1BI34.SA | Neurocrine Biosciences, Inc. | 39.64 BRL | −10.88% | −1.69% | +7.37% |
| C1OO34.SA | The Cooper Companies, Inc. | 39.92 BRL | +6.97% | −13.31% | −0.89% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | 35.30 BRL | +2.86% | −12.41% | +1.37% |
| B1AX34.SA | Baxter International Inc. | 67.70 BRL | +8.81% | +27.70% | +3.61% |
| S1NN34.SA | Smith & Nephew plc | 31.62 BRL | 0.00% | −9.99% | −20.44% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | 166.77 BRL | +12.08% | −0.14% | +4.97% |
| R1VT34.SA | Revvity, Inc. | 20.60 BRL | +3.00% | +10.27% | +22.81% |
| DVAI34.SA | DaVita Inc. | 938.25 BRL | −23.86% | +44.22% | +18.80% |
| T1CH34.SA | Bio-Techne Corporation | 12.60 BRL | +4.13% | +17.24% | +23.42% |
| A1LG34.SA | Align Technology, Inc. | 208.52 BRL | −5.78% | −2.37% | +7.83% |
| I1QV34.SA | IQVIA Holdings Inc. | 84.64 BRL | −67.80% | −72.39% | −67.19% |
| U1HS34.SA | Universal Health Services, Inc. | 230.44 BRL | +11.86% | −26.92% | −6.44% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.